China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective clinical research protocol for constructing a predictive model for the kinetics of ctDNA release during the perioperative period of lung cancer and the status of minimal residual disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133227

Registration Time: 2026/09/23

Type: Observational study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344813

Published by HT Digital Content Services with permission from Health Daily Digest....